ATC
BMY icon

Argent Trust Co’s Bristol-Myers Squibb BMY Stock Holding History

Argent Trust Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.37M Buy
137,984
+88,280
+178% +$5.15M 0.28% 84
2025
Q4 		$2.68M Sell
49,704
-9,287
-16% -$447K 0.09% 191
2025
Q3 		$2.66M Sell
58,991
-4,308
-7% -$201K 0.09% 192
2025
Q2 		$2.93M Sell
63,299
-8,063
-11% -$396K 0.11% 173
2025
Q1 		$4.35M Sell
71,362
-1,039
-1% -$60.6K 0.18% 121
2024
Q4 		$4.09M Buy
72,401
+587
+0.8% +$32.8K 0.17% 122
2024
Q3 		$3.72M Sell
71,814
-2,509
-3% -$118K 0.15% 134
2024
Q2 		$3.09M Sell
74,323
-27,780
-27% -$1.24M 0.14% 146
2024
Q1 		$5.54M Sell
102,103
-5,264
-5% -$268K 0.25% 89
2023
Q4 		$5.51M Buy
107,367
+1,107
+1% +$58.1K 0.27% 84
2023
Q3 		$6.17M Buy
106,260
+5,463
+5% +$335K 0.34% 70
2023
Q2 		$6.45M Buy
100,797
+1,723
+2% +$116K 0.35% 67
2023
Q1 		$6.87M Buy
99,074
+2,991
+3% +$211K 0.44% 60
2022
Q4 		$6.91M Sell
96,083
-2,418
-2% -$182K 0.46% 60
2022
Q3 		$7M Buy
98,501
+1,935
+2% +$140K 0.51% 50
2022
Q2 		$7.43M Buy
96,566
+817
+0.9% +$62.2K 0.51% 52
2022
Q1 		$6.99M Sell
95,749
-7,638
-7% -$513K 0.43% 61
2021
Q4 		$6.45M Buy
103,387
+6,219
+6% +$365K 0.38% 64
2021
Q3 		$5.75M Buy
97,168
+1,116
+1% +$73.5K 0.37% 66
2021
Q2 		$6.42M Buy
96,052
+1,148
+1% +$74.9K 0.42% 61
2021
Q1 		$5.99M Sell
94,904
-1,827
-2% -$114K 0.42% 59
2020
Q4 		$6M Sell
96,731
-283
-0.3% -$17.4K 0.46% 56
2020
Q3 		$5.85M Buy
97,014
+9,861
+11% +$594K 0.52% 49
2020
Q2 		$5.13M Buy
87,153
+7,110
+9% +$425K 0.48% 54
2020
Q1 		$4.46M Sell
80,043
-269
-0.3% -$16.4K 0.5% 54
2019
Q4 		$5.16M Buy
80,312
+15,037
+23% +$861K 0.46% 57
2019
Q3 		$3.31M Sell
65,275
-1,133
-2% -$53.2K 0.32% 78
2019
Q2 		$3.01M Sell
66,408
-93
-0.1% -$4.33K 0.31% 81
2019
Q1 		$3.17M Sell
66,501
-2,792
-4% -$139K 0.33% 75
2018
Q4 		$3.6M Sell
69,293
-5,369
-7% -$288K 0.42% 62
2018
Q3 		$4.59M Buy
74,662
+724
+1% +$43K 0.53% 50
2018
Q2 		$4.09M Buy
73,938
+59,406
+409% +$3.21M 0.5% 58
2018
Q1 		$919K Buy
14,532
+5,490
+61% +$353K 0.26% 92
2017
Q4 		$554K Sell
9,042
-561
-6% -$35.1K 0.22% 137
2017
Q3 		$612K Buy
9,603
+1,133
+13% +$66.2K 0.24% 126
2017
Q2 		$472K Sell
8,470
-2,668
-24% -$145K 0.19% 155
2017
Q1 		$606K Buy
11,138
+3,407
+44% +$187K 0.25% 125
2016
Q4 		$452K Sell
7,731
-188
-2% -$10.3K 0.2% 156
2016
Q3 		$427K Sell
7,919
-909
-10% -$58.4K 0.18% 164
2016
Q2 		$649K Sell
8,828
-1,543
-15% -$109K 0.29% 105
2016
Q1 		$663K Buy
10,371
+868
+9% +$54.7K 0.32% 91
2015
Q4 		$654K Buy
9,503
+705
+8% +$46.6K 0.33% 97
2015
Q3 		$521K Sell
8,798
-10
-0.1% -$634 0.3% 111
2015
Q2 		$586K Sell
8,808
-3,193
-27% -$210K 0.3% 104
2015
Q1 		$774K Buy
12,001
+418
+4% +$26.2K 0.39% 76
2014
Q4 		$684K Buy
+11,583
New +$653K 0.41% 73

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Argent Trust Co's BMY Position: Q1 2026 in Review

Argent Trust Co increased its Bristol-Myers Squibb (BMY) stake by 178% in Q1 2026, buying an estimated $5.15M and bringing the position to 137,984 shares worth $8.37M. The position accounts for 0.28% of the portfolio, ranked #84.

Argent Trust Co first reported a position in BMY in Q4 2014 and has held it in 46 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Argent Trust Co held 137,984 shares of Bristol-Myers Squibb worth $8.37M as of Q1 2026.
  • Argent Trust Co bought 88,280 Bristol-Myers Squibb shares in Q1 2026, an estimated $5.15M.
  • Bristol-Myers Squibb made up 0.28% of Argent Trust Co's portfolio in Q1 2026, its #84 holding.
  • Argent Trust Co first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 46 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.